CERTARA INC (CERT:NASDAQ)
$6.77 -0.02 (-0.2946%)
Analysed CERTARA INC (CERT:NASDAQ) News Sources
Certara (CERT) Stock Sees Fair Value Edges Lower As Analysts Trim Targets
20-06-2026
yahoo.com
Will CONMED’s New CFO Shift CNMD’s Financial Playbook Or Deepen Its Existing Strategy?
21-06-2026
yahoo.com
Veristat Strengthens Biostatistics, Drug Development Advisory, and People Leadership to Support Growth in Complex Clinical Development
23-06-2026
yahoo.com
[Latest] Global In Silico Clinical Trials Market Size/Share Worth USD 8.94 Billion by 2035 at a 15.2% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
26-06-2026
yahoo.com
Is Certara (CERT) Quietly Recasting Its Small-Cap Identity Around Biosimulation Advisory Leadership?
02-07-2026
yahoo.com
Certara Accelerates Drug Discovery and Development with NVIDIA BioNeMo Agent Toolkit
07-07-2026
yahoo.com
Certara teams up with Nvidia to strengthen AI platform with BioNeMo toolkit (CERT)
07-07-2026
advfn.com
AI Chips Today - Certara-NVIDIA Partnership Revolutionizes AI in Drug Development
08-07-2026
yahoo.com
NVIDIA (NVDA): The Best NASDAQ 100 Stock to Buy Other Than SpaceX
09-07-2026
yahoo.com
Bank of America Securities Reiterates Buy Rating on Nvidia (NVDA)
10-07-2026
yahoo.com
What is the current price of CERTARA INC (CERT:NASDAQ)?
The current price of CERTARA INC (CERT:NASDAQ) is $6.77.
CERTARA INC (CERT:NASDAQ) absolute price change since previous trading day?
The absolute price change of CERTARA INC (CERT:NASDAQ) since the previous trading day is $-0.02.
CERTARA INC (CERT:NASDAQ) percentage price change since previous trading day?
The percentage price change of CERTARA INC (CERT:NASDAQ) since the previous trading day is -0.2946%.
What is the most recent average sentiment score for CERTARA INC (CERT:NASDAQ)?
The most recent average sentiment score for CERTARA INC (CERT:NASDAQ) is 83 out of 100.
What is the most recent average sentiment for CERTARA INC (CERT:NASDAQ)?
The most recent sentiment for CERTARA INC (CERT:NASDAQ) is .
SEC-8K** Filing Available For CERTARA INC (CERT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.